Carfilzomib, Lenalidomide and Dexamethasone versus Lenalidomide and Dexamethasone in High- Risk Smoldering Multiple Myeloma: A Randomized Phase II Study.
Phase of Trial: Phase II
Latest Information Update: 30 Oct 2019
Price : $35 *
At a glance
- Drugs Carfilzomib (Primary) ; Dexamethasone (Primary) ; Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- Acronyms HOVON 147 SMM-EMN15
- 19 Nov 2018 Status changed from not yet recruiting to recruiting.
- 10 Oct 2018 Planned initiation date changed from 1 Sep 2018 to 1 Nov 2018.
- 04 Jul 2018 New trial record